NA
BHC icon

Navellier & Associates’s Bausch Health BHC Stock Holding History

Navellier & Associates’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-72,851
Closed -$13M – 235
2015
Q3 		$13M Buy
72,851
+66,598
+1,065% +$15.5M 1.31% 33
2015
Q2 		$1.39M Sell
6,253
-544
-8% -$121K 0.12% 94
2015
Q1 		$1.35M Buy
6,797
+572
+9% +$101K 0.12% 90
2014
Q4 		$891K Sell
6,225
-53
-0.8% -$7.13K 0.04% 116
2014
Q3 		$824K Sell
6,278
-1,036
-14% -$123K 0.04% 119
2014
Q2 		$922K Sell
7,314
-1,701
-19% -$217K 0.04% 115
2014
Q1 		$1.19M Buy
9,015
+2,271
+34% +$311K 0.06% 84
2013
Q4 		$792K Buy
6,744
+1,471
+28% +$161K 0.04% 122
2013
Q3 		$550K Buy
5,273
+326
+7% +$31.8K 0.02% 163
2013
Q2 		$426K Buy
+4,947
New +$390K 0.02% 153

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Navellier & Associates's BHC Position: Q4 2015 in Review

Navellier & Associates sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 72,851 shares — an estimated $13M sold.

Navellier & Associates first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $13M in Q3 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Navellier & Associates reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Navellier & Associates sold 72,851 Bausch Health shares in Q4 2015, an estimated $13M.
  • Navellier & Associates first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Navellier & Associates's Bausch Health position peaked at $13M in Q3 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Navellier & Associates's 13F filing for Q4 2015, filed 10 Feb 2016.